Navigation Links
Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
Date:3/14/2008

Studies found it made difference when disease moved from colon, appendix

FRIDAY, March 14 (HealthDay News) -- In certain patients with cancer that has spread to the peritoneum -- the membrane lining the abdominal cavity -- surgery combined with a special kind of chemotherapy can improve survival rates, Wake Forest University researchers report.

The findings are from one of two Wake Forest studies presented at this week's annual meeting of the Society of Surgical Oncology in Chicago.

The first study was a phase I trial to establish the maximum tolerated dose of oxaliplatin used in Intraperitoneal Hyperthermic Chemotherapy (IPHC) in treating colorectal and appendix cancers that have spread to the peritoneum. The 15-patient study found that IPHC at a dose of 200 mg/m is well-tolerated and is the maximum tolerated dose for a two-hour chemoperfusion.

"Based on the data from this phase I study, we propose to conduct a larger trial with oxaliplatin dose to study its efficacy in improving outcomes in patients with peritoneal carcinoma," Dr. John H. Stewart IV, an assistant professor of surgery in the section of surgical oncology, said in a prepared statement.

In the second study, researchers examined the use of IPHC in patients with peritoneal or hepatic metastases (HM), or liver malignancy that has spread from colorectal cancer. The study included 144 patients (17 with liver cancer) who had surgery to remove as much of the cancer as possible, followed by IPHC.

Median overall survival for those without HM was 22.7 months, compared to 15.8 months for those with HM. This was not a significant difference, the researchers said.

The study also found that two- and four-year survival rates for the HM patients were 34 percent and 11.3 percent. The presence of malignant fluid in the abdominal cavity was a significant predictor of decreased survival among patients with HM.

More information

Cancer Research UK has more about peritoneal cancer.



-- Robert Preidt



SOURCE: Wake Forest University Baptist Medical Center, news release, March 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Radiation and drug combo helps boost efficacy of lung cancer treatment
2. Aerobic, Weight Training Combo Best Against Diabetes
3. New antibiotic drug combo to speed up treatment of tuberculosis
4. Drug Combo Helps Fight Marfan Syndrome
5. Drug Combo Blocks Pain Without Impairing Movement
6. Two-Drug Combo Fights Brain Tumors
7. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
8. Drug Combo Boosts Multiple Myeloma Survival
9. Drug Combos Effective Against Rheumatoid Arthritis
10. Combo PET/CT Scan Helps Spot Breast Cancers Spread
11. Drug Combo With Antibiotic May Slow MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... Thinksport, the most award-winning sunscreen on ... of Marin. For the second year in a row, cyclists will stay protected ... are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... National Institute for Health and Care Excellence (NICE) framework. The agreement allows ... Service (NHS) to search, order and purchase medical and healthcare-related content through ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- In conjunction with DURECT Corporation,s (Nasdaq: DRRX ... are invited to listen to a conference call that ... March 14, 2017 at 4:30 pm Eastern Time (1:30 ... of the presentation will be available by accessing DURECT,s ... If you are unable to participate during the live ...
(Date:2/24/2017)... Australien, 24. Februar 2017 ITL Limited, ... des Gesundheitsbereiches, ist erfreut, für das zum 31. ... entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine ... zum Wachstum" finden Sie hier . ... nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
Breaking Medicine Technology: